financetom
Business
financetom
/
Business
/
OpenAI CFO says new structure opens door to potential future IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI CFO says new structure opens door to potential future IPO
May 28, 2025 6:55 AM

DUBLIN (Reuters) -OpenAI's restructuring plans open the door to a potential future IPO, but any such decision would depend on the mood in public markets as well as the readiness of the company, Chief Financial Officer Sarah Friar said on Wednesday.

OpenAI, in which Microsoft ( MSFT ) has invested more than $13 billion, outlined plans in December to convert its for-profit arm into a public benefit corporation, a structure designed to balance shareholder returns with social goals, unlike nonprofits, which are solely focused on public good.

The ChatGPT-maker dialed back the plan earlier this month so that the nonprofit parent would continue to control the PBC and become a big shareholder in it, while still allowing its for-profit arm to raise more capital to keep pace in the AI race.

"A PBC gets us to an IPO-able event ... if and when we want to," Friar told the Dublin Tech Summit.

"Nobody tweet in this room that Sarah Friar just said anything about OpenAI ultimately going public," she added. "I did not. I said it could happen."

Asked what it would take for OpenAI to opt for an IPO, Friar said that any company looking at an IPO requires two things: that the company is ready and that markets are ready.

"You can show up at the altar all ready to go, and if the market's not ready for you, yeah, you're just out of luck," she said.

"Which is why you have to build a company that can be sustainable and safe regardless of where the public markets are, how open that window is."

To be a pubic company, "you definitely need some sense of predictability," Friar added.

"The market will put up with a certain degree of unpredictability. Particularly when growth is high ... but the market doesn't really love it."

(Writing by Conor HumphriesEditing by Mark Potter)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CERAWEEK-More chance of Elvis speaking than energy transition plans succeeding, Aramco CEO says
CERAWEEK-More chance of Elvis speaking than energy transition plans succeeding, Aramco CEO says
Mar 10, 2025
By Arathy Somasekhar and Maha El Dahan HOUSTON, March 10 (Reuters) - Policymakers and energy executives need to rethink energy transition plans and stop doubling down on elements of the transition that have failed, the CEO of state oil giant Saudi Aramco said on Monday, stressing the need for investment in fossil fuels to meet global demand. The comments from...
Knife River Wraps Up $454 Million Buyout of Strata
Knife River Wraps Up $454 Million Buyout of Strata
Mar 10, 2025
10:20 AM EDT, 03/10/2025 (MT Newswires) -- Knife River (KNF) said Monday it has completed its $454 million acquisition of rival construction materials supplier. Knife River said it has started the process of integrating Strata's operations and expects the deal to produce profitable returns beginning this year. Knife River will update its 2025 financial outlook when it reports its Q1...
Electromed Reports $5 Million Share Buyback Plan
Electromed Reports $5 Million Share Buyback Plan
Mar 10, 2025
10:17 AM EDT, 03/10/2025 (MT Newswires) -- Electromed ( ELMD ) said Monday its board has authorized the repurchase of up to $5 million of its shares. The timing and amount of buybacks will be determined based on market conditions and other considerations, the company said. Price: 25.75, Change: +0.32, Percent Change: +1.24 ...
Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says
Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says
Mar 10, 2025
March 10 (Reuters) - Eli Lilly ( LLY ) plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, Brazil and Mexico by 2026, Chief Financial Officer Lucas Montarce said on Monday. The size is significant. We're talking about 900 million patients that could benefit from Mounjaro, Montarce said at the Leerink Partners Global Healthcare...
Copyright 2023-2026 - www.financetom.com All Rights Reserved